FDA: Update on Serological Test Validation and Education Efforts
FDA notes as the country starts to see positive signs that the mitigation efforts, like stay-at-home orders and social distancing, are working in our fight against the COVID-19 pandemic, the question of when we can return to work and resume our normal activities is one of the most critical issues facing our nation.
FDA Approves First New Drug Under International Collaboration, A Treatment Option for Patients with HER2- Positive Metastatic Breast Cancer
The FDA collaborated with the Australian Therapeutic Goods Administration (TGA), Health Canada, Health Sciences Authority (HSA, Singapore) and Swissmedic (SMC, Switzerland) on this review.
COVID-19 Microneedle Vaccine Delivery, to Enhance Efficiency and Reduce Dose In the Works
Debiotech will be collaborating with vaccine companies, foundations and public organizations, using its unique DebioJect™ COVID-19 Microneedle, to improve the effectiveness of COVID-19 vaccines by reducing the necessary dose to achieve a sufficient immune response.
TriAltus Bioscience Protein Purification Technology Supports Providence Cancer Institute COVID-19 Vaccine Development
“It’s rewarding to know that our product can help expedite the search for a COVID-19 vaccine,” said TriAltus Bioscience CEO Bob Shufflebarger. “Our CL7/Im7 system is helping Dr. Hu and his colleagues attain high protein purity in a single-step process that saves critical time and boosts research productivity.”
Getinge Online Enables Hospitals to Improve Efficiency by Using Product Data to Gain Insights and Maximize Uptime
Getinge Online, part of the service offering Getinge Care, is a digital platform to which hospitals can connect their Getinge products to transfer equipment data.